A little-known fact is that Senator Ted Cruz spent time at the FTC during a time when there were, as he reflects, certain bipartisan...

In the continuing debate over the uptake of biosimilars, FDA recently put a stake in the ground by recommending in a new labeling...

Since President Biden's July 2021 executive order directing the FDA Commissioner to collaborate with the PTO on potential misuse of the...

The late and great tennis writer and broadcaster Bud Collins loved loud pants (Google it), nicknames (ditto), and “net cords,”* those...

Whether an argument raised in a Petitioner Reply falls within the scope of permissible arguments following a Patent Owner Response (POR)...

Less than two months ago, the FTC faced at least five separate lawsuits challenging the constitutionality of the agency in response to...

We are proud to support the National Asian Pacific Bar Association as it holds its Annual Convention on November 9-12 in Indianapolis....

On Sunday evening, CBS's 60 Minutes aired a segment featuring “The Five Eyes” and the critical issue of state-sponsored intellectual...

I remember my years renting apartments in Manhattan - with absolute dread! Every time I had to move, it seemed that the brokers and...

In ABS Global, Inc. v. Cytonome/ST, LLC, No. 2022-1761, 2023 WL 6885009 (Fed. Cir. Oct. 19, 2023), the Federal Circuit issued a...

Last week, Avanci announced a licensing program for video codecs.  Avanci, of course, is a big name in the development of patent...

DOJ’s announcement of a safe harbor for voluntary self-disclosure in the context of acquisitions is the latest policy change in support...

The FTC recently issued a policy statement warning drug manufacturers that it “intends to scrutinize improper Orange Book listings” and...

A hip-hop artist has blamed his trial loss on AI used in the closing. After asking for a new trial, will there be a claim for...

The continuing debate as to where to draw the line between encouraging innovation and lowering drug costs was front and center during a...

The Panduit test for determining lost profits in a patent case is almost fifty years old. The four-factor test doesn't exactly roll off...